Beam Therapeutics

+$5.78 (+8.74%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BEAM and other stocks, options, and ETFs commission-free!

About BEAM

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing.

CEO
John Evans
Employees
181
Headquarters
Cambridge, Massachusetts
Founded
2017

BEAM Key Statistics

Market Cap
4.50B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.10M
High Today
$72.86
Low Today
$66.01
Open Price
$66.79
Volume
804.40K
52 Week High
$126.90
52 Week Low
$18.76

BEAM Earnings

-$3.35
-$2.23
-$1.12
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.74 per share
Actual
-$3.35 per share

You May Also Like

IRR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure